1. Introduction {#sec1-nutrients-10-00387}
===============

Glaucoma is a leading cause of loss of sight, affecting more than 70 million people worldwide \[[@B1-nutrients-10-00387],[@B2-nutrients-10-00387]\]. The pathogenesis of glaucoma is not fully established, although intraocular pressure (IOP) is the most critical and treatable risk factor. Glaucoma develops even within a normal IOP range and can progress, even with a substantial decrease in IOP. Excitotoxicity, unstable blood flow and oxidative stress can also affect the development and progression of glaucoma \[[@B3-nutrients-10-00387]\].

A family history of glaucoma is one of the risk factors for primary open-angle glaucoma (POAG) \[[@B4-nutrients-10-00387]\]. Family members have a high probability of having common genetic susceptibility or similar lifestyles, such as diet. Given those findings, different genes or environmental factors may be linked to the development of glaucoma. To date, identified gene mutations are responsible for \<10% of POAG in the general population \[[@B5-nutrients-10-00387]\]. An active interest in environmental or lifestyle factors, such as diet patterns, and their association with glaucoma may be needed to understand the pathogenesis of glaucoma.

The most common type of open-angle glaucoma in Asian countries is normal tension glaucoma (NTG), whereas high tension glaucoma is more common in the United States and Europe \[[@B6-nutrients-10-00387]\]. Staple foods and dietary habits are distinctly different between Asian and Caucasian individuals, even though the prevalence of a Westernized diet has increased in Asian countries. The proportion of NTG in a Japanese American population was 80.4% of all POAG cases, which was lower than 92.3% in the Tajimi Study conducted in Japan. One of the reasons for the lower rate of NTG in the Japanese American population may be differences in environmental factors such as nutrition \[[@B7-nutrients-10-00387],[@B8-nutrients-10-00387]\].

Accumulating clinical evidence suggests a possible association between nutrition or diet composition and POAG \[[@B9-nutrients-10-00387],[@B10-nutrients-10-00387],[@B11-nutrients-10-00387],[@B12-nutrients-10-00387],[@B13-nutrients-10-00387]\], although a few studies did not find this correlation \[[@B14-nutrients-10-00387],[@B15-nutrients-10-00387]\]. Lower ingestion of retinol equivalents, vitamins B2 and C, a higher ratio of *n*-3 to *n*-6 polyunsaturated fats, and a lower ingestion of certain fruits or vegetables have been found to be related to the risk for POAG \[[@B9-nutrients-10-00387],[@B10-nutrients-10-00387],[@B11-nutrients-10-00387],[@B12-nutrients-10-00387],[@B13-nutrients-10-00387]\]. Among nutrients, vitamins with anti-oxidant activity are of interest, as they may relieve oxidative stress in the pathogenesis of glaucoma \[[@B16-nutrients-10-00387],[@B17-nutrients-10-00387]\].

To date, no study has addressed the relationship between diverse dietary nutrients and glaucoma in Asian countries. In this study, we investigated the potential impact of dietary nutrients on glaucoma using the Korean National Health and Nutrition Examination Survey (KNHANES), a large population-based study. Determination of modifiable risk factors, aside from IOP, can provide other options for treating glaucoma patients showing progression of the disease, despite a relatively low IOP range.

2. Methods {#sec2-nutrients-10-00387}
==========

The KNHANES is an ongoing nationwide epidemiological study conducted by the Division of Chronic Disease Control and Prevention, Ministry of Health and Welfare, with the approval of its Institutional Review Board. The survey follows the tenets of the Declaration of Helsinki for biomedical research involving humans. Written informed consent was provided by all participants. The KNHANES uses a stratified, multistage, probability cluster survey with a rolling survey model. All participants are randomly chosen from randomly assigned districts of cities and provinces in South Korea.

Among the 37,982 participants in the KNHANES 2008--2012 IV--V, those who were younger than 40 years old or who did not complete an ophthalmic examination were excluded. Other exclusion criteria were as follows: participants with a narrow angle using the Van Herick method (peripheral anterior chamber depth ≤4/1 of peripheral corneal thickness); those whose fundus photograph displayed geographic atrophy or signs of wet age-related macular degeneration, such as retinal pigment epithelial (RPE) detachment, serous detachment of the sensory retina, sub-retinal or sub-RPE hemorrhage, or sub-retinal fibrous scars; those who had not completed the nutritional survey; and those with missing data.

Data on anthropometrics and demographic characteristics, including socioeconomic status and levels of education and physical activity, were collected. Participants were divided into nondrinkers, mild drinkers (≤one time per month), moderate drinkers (\>one time and ≤four times per month) and heavy drinkers (\>four times per month). Smoking status was classified into nonsmokers, former smokers, and current smokers. Physical activity (PA) scores were categorized based on the International PA Questionnaire guidelines. Moderate physical activity was defined as the performance of moderate-intensity physical activity for ≥20 min 3--4 times/week. The definition of moderate intensity was exercise that induced a mild elevation in breathing or heart rate for at least 10 min. Data on medical comorbidities, such as diabetes mellitus and hypertension, were also collected as potential confounding variables. Diabetes was defined as a fasting blood glucose level higher than 126 mg/dL or the current use of a systemic antidiabetic treatment. Systemic hypertension was defined as a systolic blood pressure (BP) \> 160 mmHg, diastolic BP \> 90 mmHg, or the current use of a systemic antihypertensive medication.

2.1. Ophthalmologic Measurements {#sec2dot1-nutrients-10-00387}
--------------------------------

Participants underwent ophthalmological examinations, including slit-lamp examinations and fundus photography. Ophthalmologists measured IOP using a Goldmann applanation tonometer (Haag-streit, Inc., Bern, Switzerland).

Participants with elevated IOP (≥22 mmHg) or a glaucomatous optic disc were examined using frequency-doubling technology (Humphrey Matrix; Carl Zeiss Meditec, Inc., Jena, Germany) using the N-30-1 program. A glaucomatous optic disc refers to any of the following: a horizontal or vertical cup-to-disc ratio (vCDR) of ≥0.5, the appearance of optic disc hemorrhage, the presence of a retinal nerve fiber layer defect (RNFL), or a violation of the ISNT rule (neuroretinal rim thickness in the order of inferior \> superior \> nasal \> temporal). Subjects underwent the test again when fixation errors or false-positive errors were \>33%. A glaucoma diagnosis was made using modified ISGEO criteria \[[@B18-nutrients-10-00387],[@B19-nutrients-10-00387]\]: when both fixation errors and false-positive errors were 33% or less, category 1 requires a glaucomatous visual field defect with a CDR of ≥0.7, asymmetry of a vCDR of ≥0.2, or the presence of an RNFL defect \[[@B18-nutrients-10-00387],[@B19-nutrients-10-00387]\]. When the visual field was not available or was unsatisfactory, subjects were included in category 2 if their vCDR was ≥0.9, the vCDR asymmetry was ≥0.3 or if they had an RNFL loss with a violation of the ISNT rule \[[@B19-nutrients-10-00387]\]. If examinations of the optic disc and visual field tests were not possible, category 3 required a visual acuity of \<3/60 and IOP exceeding 21 mmHg \[[@B18-nutrients-10-00387]\]. Subgroup analysis was done within subjects with NTG; NTG was defined as an IOP was ≤21 mmHg.

2.2. Assessment of Nutrient Intake {#sec2dot2-nutrients-10-00387}
----------------------------------

Dietary intake was determined using the 24 h recall method by trained staff. All subjects were instructed to continue their ordinary diets before the dietary evaluation. The information gained on holidays or weekends was not excluded. Nutrient intake was calculated on the basis of the nutrient concentrations in foods using the Korean Food Composition Table, which was devised by the Korean National Rural Resources Development Institute \[[@B20-nutrients-10-00387]\]. Fiber (g/day), ash (g/day), calcium (mg/day), phosphorus (mg/day), iron (mg/day), sodium (mg/day), potassium (mg/day), β-Carotene (μg/day), retinol (μg/day), thiamine (mg/day), riboflavin (mg/day), niacin (mg/day), and Vitamin C (mg/day) were included in nutrient intake data. vitamin A (μg Retinol Equivalents (RE)/day) was calculated by summing retinol (μg/day) and β-Carotene/6 (μg/day). The individuals were divided into quartiles of total intake per day for each nutrient (Q1, Q2, Q3 and Q4). If individuals had taken any kind of supplements consecutively more than 2 weeks over the past year or more than one time per week over the past month, they were regarded as taking supplements.

2.3. Statistical Analyses {#sec2dot3-nutrients-10-00387}
-------------------------

SAS Software (version 9.2; SAS Institute, Inc., ‎Cary, NC, USA) was used for statistical analyses to reflect sampling weights and to offer nationally representative prevalence estimates. Demographic factors between subjects with and without glaucoma were compared using Student's *t*-tests for continuous parameters and *χ*^2^ tests for categorical variables. Continuous and categorical parameters are described as the mean ± standard error and percentage, respectively. Multivariate adjusted logistic analysis was performed to investigate factors associated with glaucoma. We analyzed the subset of data after excluding subjects taking supplements. Factors with a difference of *p* \< 0.1 between the two groups, IOP, and total energy were entered into a multivariate analysis. Odds ratios (ORs) and 95% confidence intervals were calculated. A *p* value of \<0.05 was considered statistically significant.

3. Results {#sec3-nutrients-10-00387}
==========

Among 37,982 participants in the KNHANES 2008--2012 IV--V, those younger than 40 years old were excluded (*n* = 17,563). Subjects who did not receive an ophthalmic examination were also excluded (*n* = 95). Participants with a narrow angle using the Van Herick method (peripheral anterior chamber depth ≤4/1 of peripheral corneal thickness; *n* = 350), those whose fundus photograph displayed geographic atrophy or signs of wet age-related macular degeneration, such as retinal pigment epithelial (RPE) detachment, serous detachment of the sensory retina, sub-retinal or sub-RPE hemorrhage, or sub-retinal fibrous scars (*n* = 123), those who had not completed the nutritional survey (*n* = 2030), and those with missing data (*n* = 757) were excluded. A total 16,770 participants (6902 men, 9868 women) were included in this study ([Figure 1](#nutrients-10-00387-f001){ref-type="fig"}).

The demographics are shown in [Table 1](#nutrients-10-00387-t001){ref-type="table"}. Seven hundred and seventy-five participants were diagnosed with glaucoma (overall prevalence, 4.11%). The proportion of individuals with glaucoma diagnosis made in the absence of visual field defects and/or abnormal optic disc parameters was 47.4%. The average age of participants with glaucoma was 60.7 ± 0.6 years old. Subjects with glaucoma were older and less educated, exercised less regularly, were more likely to smoke, have no occupation, and have diabetes or hypertension than those without glaucoma (all *p* \< 0.05). IOP was higher in subjects with glaucoma (14.7 ± 0.2 mmHg) than in those without glaucoma (14.0 ± 0.1 mmHg, *p* \< 0.001).

Quartile categories of each nutrient intake are displayed in [Table 2](#nutrients-10-00387-t002){ref-type="table"}.

With regard to nutrients, intake of crude fiber, ash, calcium, phosphorus, iron, sodium, potassium, vitamin A, β-Carotene, retinol, thiamin, riboflavin, niacin, and vitamin C was associated with glaucoma (all *p* \< 0.05; [Table 3](#nutrients-10-00387-t003){ref-type="table"}).

Multivariate analyses (model 1) adjusted for age, gender, income status, education level, smoking, alcohol consumption, physical activity, diabetes, hypertension, IOP, and total energy, showed intake of niacin was correlated with glaucoma (*p* = 0.013; [Table 4](#nutrients-10-00387-t004){ref-type="table"}). In a partially adjusted model (all covariates in model 1 but IOP), overall results were similar to those in model 1 multivariate analyses.

IOP distributions by nutrient quartiles are displayed in [Table 5](#nutrients-10-00387-t005){ref-type="table"}. The mean IOP did not differ according to nutrient quartiles.

Subgroup analyses showed that for subjects with IOP ≤ 21 mmHg (*n* = 767, 98.9% of total glaucoma patients), only lower niacin intake was associated with a higher odds ratio for glaucoma (*p* = 0.022; [Table 6](#nutrients-10-00387-t006){ref-type="table"}).

After the exclusion of individuals taking supplements, higher intake of riboflavin (*p* = 0.009) and niacin (*p* = 0.035) were related to a lower risk of glaucoma ([Table 7](#nutrients-10-00387-t007){ref-type="table"}). Among subjects without glaucoma, 4100 subjects (25.6%) were taking supplements. Among individuals with glaucoma, 193 individuals (24.9%) were taking supplements.

4. Discussion {#sec4-nutrients-10-00387}
=============

We demonstrated that dietary intake of niacin was associated with glaucoma, independent of IOP. Mean IOP was similar by quartiles of all examined nutrients. Individuals with NTG showed lower intake of niacin among nutrients. After the exclusion of individuals taking supplements, higher intake of riboflavin and niacin were related to a lower risk of glaucoma. Overall, lower intake of niacin remained significantly associated with glaucoma also in the subgroup analysis.

Previously, some reports found that low intake of vitamins was associated with augmented risk for glaucoma \[[@B11-nutrients-10-00387],[@B13-nutrients-10-00387]\]. The Rotterdam study, a prospective population-based study, reported that a low intake of retinol equivalents and vitamin B1 appeared to increase the risk for POAG \[[@B11-nutrients-10-00387]\]. Wang et al. suggested that supplementary ingestion of vitamin C was associated with reduced glaucoma risk \[[@B13-nutrients-10-00387]\]. The Nurses' Health Study and Health Professionals Follow-up Study did not detect a correlation between nutrients with anti-oxidant properties and open-angle glaucoma \[[@B14-nutrients-10-00387]\]. However, the diagnosis of glaucoma was based on self-report, even though a strength of that study was that it was a large prospective study \[[@B14-nutrients-10-00387]\]. This could result in a selection bias because over half of individuals with glaucoma are not aware of their condition \[[@B21-nutrients-10-00387],[@B22-nutrients-10-00387]\].

IOP is the most critical risk factor for glaucoma, even though glaucoma can develop in cases with a normal range of IOP. We analyzed IOP distribution by quartiles of dietary nutrients and found no significant differences in mean IOP according to dietary nutrients. The relationship between nutrients and glaucoma was analyzed adjusting for IOP to remove the influence of dietary nutrient intake on IOP. There was an association between dietary intake of niacin with glaucoma, independent of IOP.

With regard to NTG, only one Japanese study observed that lower *serum* vitamin C levels were correlated with increased risk of NTG \[[@B23-nutrients-10-00387]\]. The authors speculated that glutamate-stimulated release of vitamin C might decrease oxidative stress induced by glutamate excitotoxicity and reduce the degeneration of retinal ganglion cells \[[@B23-nutrients-10-00387]\]. The difference between that study and this study is that only vitamin A, B9, C, E and uric acid were investigated using *serum* samples, and niacin was not included in that study \[[@B23-nutrients-10-00387]\].

In this study, only dietary niacin intake was lower in subjects with NTG. In addition, niacin remained as the factor associated with glaucoma after the exclusion of subjects taking supplements. Recently, Williams et al. found that oral administration of vitamin B3 protected retinal ganglion cells in aged mouse with chronic ocular hypertension, modulating mitochondrial vulnerability \[[@B24-nutrients-10-00387]\]. In a stroke animal model, niacin (nicotinic acid) treatment promoted synaptic plasticity and axon growth \[[@B25-nutrients-10-00387]\]. That study suggested that brain-derived neurotrophic factor (BDNF)/tropomyosin receptor kinase B (TrKB) pathways seemed to be involved in niacin-induced neuroprotective effects after a stroke \[[@B25-nutrients-10-00387]\]. Disrupted axonal transport of neurotrophic factors is one of main mechanisms of glaucoma \[[@B3-nutrients-10-00387]\]. Therefore, upregulated BDNF by niacin treatment might decrease the risk of glaucoma. Kaplon et al. reported that niacin intake was positively correlated with better vascular endothelial function associated with decreased vascular oxidative stress \[[@B26-nutrients-10-00387]\]. The vascular hypothesis for glaucoma pathogenesis states insufficient or unstable blood supply is a key contributing factor for glaucoma development or progression \[[@B27-nutrients-10-00387]\]. A collaborative normal tension glaucoma study showed vascular factors, such as disc hemorrhage and migraine, were risk factors for the progression of glaucoma \[[@B28-nutrients-10-00387]\]. Compromised vascular endothelial cell function has been reported in subjects with NTG \[[@B29-nutrients-10-00387],[@B30-nutrients-10-00387]\]. Therefore, it appears that improved vascular endothelial cell function induced by niacin could lower the risk for open-angle glaucoma. To the best of our knowledge, this is the first study to reveal the relationship between niacin and glaucoma in human. However, the study was simply descriptive and inconclusive on disease mechanisms. Measurement of serum or intravitreal level of niacin in glaucoma patients would be helpful to understand the mechanism of how low niacin influences glaucoma.

The strength of this population-based study is that study participants were representative of subjects with glaucoma in the general population. We present the first study analyzing the relationship between dietary nutrients and glaucoma (especially NTG) in an Asian country. One limitation of this study is that we could not determine cause and effect for the relationship between dietary nutrients and glaucoma. Prospective randomized controlled trial or epidemiological cohort studies are needed to ensure the usefulness of niacin in glaucoma. Another limitation is that the nutritional survey was conducted just once, although all subjects were educated to continue their ordinary diets before the dietary evaluation. There might be a confounding effect of seasonal foods because all participants did not take part in the nutritional survey at the same time of year. The proportion of participants taking dietary reference intakes for Koreans (KDRIs) was relatively lower for calcium (67.0 ± 0.8%) and potassium (61.9 ± 0.6%), according to data from the Korea National Health and Nutrition Examination Survey (2012). Therefore, the association of glaucoma with the intake of these nutrients might be underestimated. Nutrient intake was calculated on the basis of the nutrient concentrations in foods using the Korean Food Composition Table. Potential errors can exist in the tables that describe foods. The errors may result in inaccurate measurement of nutrient intake at the individual level, though probably less so at the group level. The Korean Food Composition Tables cover nearly 3000 food items in 19 groups, being almost complete for nutritional evaluation of daily foods. Kim et al. reported the accuracy of conventional food composition table-based estimation of intakes of protein, lipid and carbohydrate, in comparison with chemical analysis \[[@B31-nutrients-10-00387]\]. Their result supports that the Korean Food Composition Tables are sufficiently accurate, even though that study did not evaluate the accuracy of niacin. Analysis from dietary nutrients has limitations because the bioavailability of nutrients may vary in each individual. Further, serum analysis of nutrients may be needed to investigate the direct association of glaucoma and nutrients.

5. Conclusions {#sec5-nutrients-10-00387}
==============

In conclusion, this population-based study found that lower nutrient intake of niacin was associated with glaucoma. Lower niacin intake was associated with NTG. In addition, niacin remained as the factor related to glaucoma after the exclusion of subjects taking supplements. Glaucoma is a progressive neurodegenerative disease and can lead to vision loss, despite a substantial decrease in IOP. The prevention of glaucoma is important, because neurodegeneration of retinal ganglion cells is irreversible. Dietary nutrition is a modifiable factor; the discovery that nutrition can help decrease glaucoma development or progression may help individuals with glaucoma even though this needs confirmation from longitudinal, prospective studies.
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nutrients-10-00387-t001_Table 1

###### 

Baseline characteristics.

  Characteristics                           Glaucoma         *p* Value     
  ----------------------------------------- ---------------- ------------- ---------
  Age (years)                               55.2 ± 0.2       60.7 ± 0.6    \<0.001
  Gender                                                                   
  Male                                      6552 (47.83)     350 (54.36)   0.006
  Female                                    9443 (52.17)     425 (45.64)   
  BMI (kg/m^2^)                                                            
  Underweight (\<18.5)                      492 (2.78)       35 (4.18)     0.108
  Normal weight (≥18.5, \<23)               5825 (35.69)     296 (37.78)   
  Overweight (≥23, \<25)                    4137 (25.86)     198 (26.64)   
  Obese (≥25)                               5541 (35.67)     246 (31.40)   
  Income status                                                            
  Lowest                                    4155 (20.39)     296 (29.25)   \<0.001
  Lower middle                              3985 (25.60)     183 (24.31)   
  Higher middle                             3794 (26.20)     136 (21.69)   
  Highest                                   4061 (27.80)     160 (24.75)   
  Education                                                                
  Elementary school or less                 6199 (30.74)     409 (44.64)   \<0.001
  Middle school graduate                    2466 (15.65)     98 (12.31)    
  High school graduate                      4503 (32.79)     161 (24.42)   
  University graduate or higher             2827 (20.81)     107 (18.63)   
  Occupation                                                               
  White collar                              2047 (16.55)     53 (9.71)     \<0.001
  Blue collar                               7142 (47.74)     323 (44.42)   
  Inoccupation                              6806 (35.71)     399 (45.87)   
  Smoking                                                                  
  Never                                     9760 (54.90)     437 (48.41)   0.015
  Former                                    3961 (29.25)     192 (31.19)   
  Current                                   2274 (15.85)     146 (20.41)   
  Alcohol intake (n)                                                       
  Non-drink                                 5705 (30.22)     327 (35.28)   0.064
  ≤1 in month                               4322 (26.72)     194 (25.44)   
  ≤4 in month                               2697 (18.75)     102 (14.85)   
  ≥2 in week                                3271 (24.32)     152 (24.44)   
  Region of residence                                                      
  Rural                                     6134 (33.24)     329 (35.37)   0.356
  Urban                                     9861 (66.76)     446 (64.63)   
  Physical activity (≥moderate intensity)                                  
  No                                        12,473 (77.72)   632 (81.48)   0.047
  Yes                                       3522 (22.28)     143 (18.52)   
  Diabetes                                                                 
  No                                        13,798 (87.43)   612 (79.88)   \<0.001
  Yes                                       2197 (12.57)     163 (20.12)   
  Hypertension                                                             
  No                                        9638 (64.21)     370 (49.72)   \<0.001
  Yes                                       6357 (35.79)     405 (50.28)   
  Intraocular pressure (mmHg)               14.0 ± 0.1       14.7 ± 0.2    \<0.001

Data are presented as mean ± SE, *n* (weighted %). Statistics were carried out using *t*-test, Rao-Scott Chi-square.

nutrients-10-00387-t002_Table 2

###### 

Quartile categories of nutrient intake.

  Nutrient                                 Q1          Q2         Q3         Q4
  ---------------------------------------- ----------- ---------- ---------- ----------
  Total energy intake (kcal)               \<1387.6    ≥1387.6    ≥1814.5    ≥2352.1
  Crude fiber (g/day)                      \<4.54      ≥4.54      ≥6.77      ≥9.72
  Ash (g/day)                              \<12.53     ≥12.53     ≥18.13     ≥25.30
  Calcium (mg/day)                         \<283.08    ≥283.08    ≥436.92    ≥645.29
  Phosphorus (mg/day)                      \<807.97    ≥807.97    ≥1083.58   ≥1444.31
  Iron (mg/day)                            \<8.63      ≥8.63      ≥12.90     ≥19.00
  Sodium(mg/day)                           \<2731.53   ≥2731.53   ≥4239.08   ≥6368.29
  Potassium (mg/day)                       \<2005.32   ≥2005.32   ≥2824.62   ≥3884.43
  Vitamin A (μg Retinol Equivalents/day)   \<316.68    ≥316.68    ≥602.05    ≥1050.90
  β-Carotene (μg/day)                      \<1556.89   ≥1556.89   ≥3103.72   ≥5586.47
  Retinol (μg/day)                         \<8.45      ≥8.45      ≥41.02     ≥105.74
  Thiamin (mg/day)                         \<0.78      ≥0.78      ≥1.11      ≥1.57
  Riboflavin (mg/day)                      \<0.67      ≥0.67      ≥1.03      ≥1.49
  Niacin (mg/day)                          \<10.15     ≥10.15     ≥14.42     ≥20.49
  Vitamin C (mg/day)                       \<50.48     ≥50.48     ≥85.71     ≥141.21

nutrients-10-00387-t003_Table 3

###### 

The association between dietary nutrient intakes and glaucoma.

  Nutrient        Gender = Male   *p* Value     Nutrient   Gender = Female   *p* Value                    
  --------------- --------------- ------------- ---------- ----------------- -------------- ------------- ---------
  Energy intake                                            Energy intake                                  
  Q1              815 (10.54)     70 (16.87)    0.002      Q1                3600 (38.05)   178 (40.00)   0.130
  Q2              1469 (19.86)    89 (25.66)               Q2                2814 (29.36)   151 (33.68)   
  Q3              1907 (28.95)    92 (23.43)               Q3                2033 (21.69)   69 (18.65)    
  Q4              2361 (40.65)    99 (34.04)               Q4                996 (10.90)    27 (7.66)     
  Crude fiber                                              Crude fiber                                    
  Q1              1208 (17.25)    70 (21.55)    0.368      Q1                3014 (31.70)   165 (39.68)   0.009
  Q2              1597 (23.80)    83 (24.28)               Q2                2420 (26.06)   113 (27.20)   
  Q3              1807 (28.43)    90 (26.67)               Q3                2070 (22.02)   81 (18.74)    
  Q4              1940 (30.53)    107 (27.50)              Q4                1939 (20.22)   66 (14.38)    
  Ash                                                      Ash                                            
  Q1              1107 (14.07)    79 (22.45)    0.003      Q1                3362 (34.44)   190 (43.36)   0.011
  Q2              1512 (21.62)    77 (19.40)               Q2                2641 (28.29)   114 (26.32)   
  Q3              1795 (28.28)    97 (29.71)               Q3                2047 (21.96)   74 (20.27)    
  Q4              2138 (36.03)    97 (28.44)               Q4                1393 (15.30)   47 (10.05)    
  Calcium                                                  Calcium                                        
  Q1              1258 (15.97)    82 (25.02)    0.004      Q1                3231 (32.70)   175 (40.03)   0.022
  Q2              1586 (24.11)    88 (20.81)               Q2                2434 (25.90)   106 (27.90)   
  Q3              1774 (28.41)    77 (21.55)               Q3                2047 (22.32)   76 (17.09)    
  Q4              1934 (31.51)    103 (32.62)              Q4                1731 (19.07)   68 (14.98)    
  Phosphorus                                               Phosphorus                                     
  Q1              985 (12.69)     70 (19.80)    0.019      Q1                3480 (35.78)   194 (44.55)   0.006
  Q2              1467 (20.87)    89 (22.29)               Q2                2708 (28.80)   118 (27.51)   
  Q3              1865 (28.56)    91 (25.07)               Q3                2009 (21.93)   78 (19.82)    
  Q4              2235 (37.88)    100 (32.83)              Q4                1246 (13.48)   35 (8.12)     
  Iron                                                     Iron                                           
  Q1              1235 (16.00)    84 (25.42)    0.004      Q1                3216 (32.57)   179 (42.70)   0.004
  Q2              1555 (23.38)    80 (19.26)               Q2                2456 (26.67)   108 (26.11)   
  Q3              1783 (28.56)    90 (27.55)               Q3                1997 (21.91)   75 (17.85)    
  Q4              1979 (32.06)    96 (27.76)               Q4                1774 (18.85)   63 (13.33)    
  Sodium                                                   Sodium                                         
  Q1              1085 (13.85)    73 (18.58)    0.019      Q1                3418 (35.00)   171 (38.55)   0.584
  Q2              1499 (21.47)    69 (19.72)               Q2                2669 (28.31)   120 (28.51)   
  Q3              1833 (28.65)    112 (33.91)              Q3                1974 (21.51)   78 (18.91)    
  Q4              2135 (36.03)    96 (27.78)               Q4                1382 (15.18)   56 (14.03)    
  Potassium                                                Potassium                                      
  Q1              1154 (15.07)    76 (22.76)    0.014      Q1                3266 (33.48)   188 (44.12)   \<0.001
  Q2              1564 (22.70)    83 (22.04)               Q2                2487 (27.10)   123 (28.56)   
  Q3              1827 (28.79)    99 (29.10)               Q3                2027 (21.66)   65 (15.86)    
  Q4              2007 (33.43)    92 (26.10)               Q4                1663 (17.76)   49 (11.46)    
  Vitamin A                                                Vitamin A                                      
  Q1              1466 (19.27)    94 (25.08)    0.150      Q1                2922 (29.68)   171 (40.06)   \<0.001
  Q2              1570 (24.15)    82 (25.32)               Q2                2439 (25.72)   108 (25.86)   
  Q3              1745 (27.53)    84 (24.42)               Q3                2094 (22.85)   92 (21.16)    
  Q4              1771 (29.05)    90 (25.18)               Q4                1988 (21.74)   54 (12.92)    
  β-Carotene                                               β-Carotene                                     
  Q1              1472 (19.69)    91 (23.99)    0.247      Q1                2876 (29.32)   173 (40.70)   \<0.001
  Q2              1577 (24.29)    83 (26.92)               Q2                2387 (25.61)   101 (23.44)   
  Q3              1724 (27.12)    85 (23.53)               Q3                2176 (23.29)   89 (20.65)    
  Q4              1779 (28.89)    91 (25.56)               Q4                2004 (21.78)   62 (15.22)    
  Retinol                                                  Retinol                                        
  Q1              1551 (19.54)    104 (24.27)   0.035      Q1                3024 (29.58)   173 (37.05)   0.004
  Q2              1728 (26.03)    101 (30.78)              Q2                2266 (23.68)   108 (27.10)   
  Q3              1564 (24.81)    85 (22.90)               Q3                2292 (25.37)   87 (22.49)    
  Q4              1709 (29.62)    60 (22.05)               Q4                1861 (21.36)   57 (13.36)    
  Thiamin                                                  Thiamin                                        
  Q1              1117 (14.11)    77 (19.68)    0.074      Q1                3368 (34.49)   190 (44.33)   0.002
  Q2              1535 (22.04)    95 (25.03)               Q2                2569 (27.60)   125 (28.17)   
  Q3              1779 (27.85)    88 (24.40)               Q3                2109 (22.69)   67 (17.41)    
  Q4              2121 (36.00)    90 (30.89)               Q4                1397 (15.22)   43 (10.09)    
  Riboflavin                                               Riboflavin                                     
  Q1              1275 (15.92)    89 (24.31)    0.005      Q1                3260 (32.59)   200 (45.37)   \<0.001
  Q2              1545 (21.93)    93 (24.04)               Q2                2646 (27.78)   117 (27.17)   
  Q3              1709 (27.34)    86 (24.57)               Q3                2056 (23.26)   60 (14.76)    
  Q4              2023 (34.81)    82 (27.08)               Q4                1481 (16.38)   48 (12.70)    
  Niacin                                                   Niacin                                         
  Q1              1037 (13.17)    75 (20.94)    0.007      Q1                3471 (35.13)   217 (48.88)   \<0.001
  Q2              1518 (21.49)    89 (23.47)               Q2                2657 (28.18)   115 (27.81)   
  Q3              1798 (27.42)    101 (25.91)              Q3                2083 (23.08)   61 (15.88)    
  Q4              2199 (37.92)    85 (29.69)               Q4                1232 (13.61)   32 (7.44)     
  Vitamin C                                                Vitamin C                                      
  Q1              1445 (20.03)    83 (22.78)    0.360      Q1                2812 (29.17)   159 (37.95)   0.008
  Q2              1662 (24.72)    90 (27.81)               Q2                2352 (25.10)   114 (25.58)   
  Q3              1748 (27.91)    94 (26.41)               Q3                2100 (22.50)   84 (19.02)    
  Q4              1697 (27.35)    83 (23.00)               Q4                2179 (23.23)   68 (17.46)    

Data are presented as *n* (weighted %). Statistics were carried out using *t*-test, Rao-Scott Chi-square test.

nutrients-10-00387-t004_Table 4

###### 

Odds ratios of nutritional factors for glaucoma.

  Nutrient      Unadjusted          Model 1   Nutrient            Unadjusted   Model 1                                                        
  ------------- ------------------- --------- ------------------- ------------ ------------ ------------------- --------- ------------------- -------
  Crude fiber                                                                  Vitamin A                                                      
  Q1            Reference                     Reference                        Q1           Reference                     Reference           
  Q2            0.85 (0.67--1.08)   0.005     0.96 (0.74--1.23)   0.221        Q2           0.79 (0.63--1.01)   \<0.001   0.99 (0.78--1.26)   0.130
  Q3            0.76 (0.59--0.98)             0.90 (0.69--1.17)                Q3           0.71 (0.55--0.91)             0.93 (0.70--1.22)   
  Q4            0.71 (0.55--0.91)             0.85 (0.63--1.13)                Q4           0.60 (0.46--0.78)             0.81 (0.61--1.07)   
  Ash                                                                          β-Carotene                                                     
  Q1            Reference                     Reference                        Q1           Reference                     Reference           
  Q2            0.69 (0.54--0.89)   0.001     0.82 (0.62--1.07)   0.369        Q2           0.79 (0.62--1.02)   \<0.001   0.97 (0.76--1.24)   0.220
  Q3            0.79 (0.61--1.01)             0.95 (0.72--1.27)                Q3           0.69 (0.53--0.90)             0.89 (0.68--1.17)   
  Q4            0.61 (0.47--0.80)             0.79 (0.55--1.14)                Q4           0.65 (0.50--0.83)             0.85 (0.65--1.12)   
  Calcium                                                                      Retinol                                                        
  Q1            Reference                     Reference                        Q1                                         Reference           
  Q2            0.74 (0.58--0.95)   0.020     0.89 (0.68--1.16)   0.615        Q2           0.97 (0.76--1.22)   \<0.001   1.14 (0.90--1.44)   0.192
  Q3            0.60 (0.46--0.78)             0.75 (0.56--0.99)                Q3           0.75 (0.59--0.95)             0.99 (0.76--1.27)   
  Q4            0.76 (0.58--1.00)             0.98 (0.72--1.33)                Q4           0.59 (0.45--0.78)             0.84 (0.63--1.13)   
  Phosphorus                                                                   Thiamin                                                        
  Q1            Reference                     Reference                        Q1           Reference                     Reference           
  Q2            0.79 (0.62--1.00)   0.006     0.87 (0.66--1.14)   0.439        Q2           0.85 (0.66--1.09)   0.002     0.97 (0.74--1.28)   0.366
  Q3            0.72 (0.56--0.93)             0.85 (0.62--1.17)                Q3           0.67 (0.52--0.88)             0.84 (0.61--1.15)   
  Q4            0.68 (0.51--0.91)             0.86 (0.55--1.33)                Q4           0.68 (0.51--0.90)             0.88 (0.60--1.30)   
  Iron                                                                         Riboflavin                                                     
  Q1            Reference                     Reference                        Q1           Reference                     Reference           
  Q2            0.66 (0.52--0.84)   0.001     0.77 (0.59--0.99)   0.075        Q2           0.74 (0.58--0.94)   \<0.001   0.88 (0.68--1.14)   0.104
  Q3            0.68 (0.52--0.90)             0.81 (0.60--1.10)                Q3           0.58 (0.45--0.75)             0.74 (0.55--1.00)   
  Q4            0.62 (0.48--0.82)             0.72 (0.52--1.00)                Q4           0.59 (0.45--0.78)             0.79 (0.54--1.15)   
  Sodium                                                                       Niacin                                                         
  Q1            Reference                     Reference                        Q1           Reference                     Reference           
  Q2            0.85 (0.67--1.09)   0.110     1.00 (0.77--1.30)   0.452        Q2           0.75 (0.58--0.95)   \<0.001   0.80 (0.61--1.06)   0.013
  Q3            0.98 (0.77--1.24)             1.22 (0.94--1.58)                Q3           0.62 (0.48--0.80)             0.69 (0.50--0.95)   
  Q4            0.77 (0.59--0.99)             1.04 (0.76--1.43)                Q4           0.57 (0.42--0.76)             0.60 (0.40--0.92)   
  Potassium                                                                    Vitamin C                                                      
  Q1            Reference                     Reference                        Q1           Reference                     Reference           
  Q2            0.76 (0.59--0.97)   \<0.001   0.88 (0.67--1.16)   0.090        Q2           0.90 (0.70--1.15)   0.004     1.08 (0.84--1.39)   0.422
  Q3            0.70 (0.53--0.92)             0.83 (0.61--1.14)                Q3           0.77 (0.59--1.00)             0.98 (0.74--1.28)   
  Q4            0.58 (0.44--0.77)             0.72 (0.49--1.05)                Q4           0.68 (0.52--0.89)             0.90 (0.67--1.22)   

Data are presented OR (95% CI). Statistics were carried out using Logistic regression. Model 1 was adjusted for age, gender, income, education, occupation, smoking, drink, physical activity, diabetes, hypertension, intraocular pressure, total energy.CI, confidence interval; OR, odds ratio.

nutrients-10-00387-t005_Table 5

###### 

Intraocular pressure according to quartiles of nutrient intake.

  Nutrient        Intraocular Pressure (mmHg)   Nutrient        Intraocular Pressure (mmHg)
  --------------- ----------------------------- --------------- -----------------------------
  Crude fiber                                   Vitamin A       
  Q1              13.95 ± 0.07                  Q1              14.05 ± 0.07
  Q2              14.00 ± 0.06                  Q2              13.94 ± 0.07
  Q3              14.08 ± 0.07                  Q3              14.01 ± 0.07
  Q4              13.97 ± 0.07                  Q4              14.00 ± 0.07
  *p* for trend   0.532                         *p* for trend   0.701
  Ash                                           β-Carotene      
  Q1              13.95 ± 0.06                  Q1              14.05 ± 0.07
  Q2              13.97 ± 0.07                  Q2              13.99 ± 0.07
  Q3              14.10 ± 0.07                  Q3              14.00 ± 0.06
  Q4              13.98 ± 0.06                  Q4              13.97 ± 0.07
  *p* for trend   0.339                         *p* for trend   0.400
  Ca                                            Retinol         
  Q1              13.98 ± 0.07                  Q1              13.90 ± 0.06
  Q2              13.99 ± 0.06                  Q2              14.03 ± 0.07
  Q3              14.07 ± 0.07                  Q3              14.07 ± 0.06
  Q4              13.96 ± 0.07                  Q4              14.01 ± 0.07
  *p* for trend   0.914                         *p* for trend   0.135
  Phosphorus                                    Thiamin         
  Q1              13.95 ± 0.07                  Q1              13.92 ± 0.07
  Q2              13.97 ± 0.06                  Q2              14.01 ± 0.07
  Q3              14.06 ± 0.06                  Q3              13.99 ± 0.07
  Q4              14.03 ± 0.07                  Q4              14.09 ± 0.07
  *p* for trend   0.186                         *p* for trend   0.054
  Iron                                          Riboflavin      
  Q1              13.96 ± 0.07                  Q1              13.97 ± 0.06
  Q2              14.02 ± 0.07                  Q2              13.93 ± 0.07
  Q3              14.02 ± 0.06                  Q3              14.04 ± 0.07
  Q4              14.01 ± 0.07                  Q4              14.07 ± 0.07
  *p* for trend   0.551                         *p* for trend   0.089
  Sodium                                        Niacin          
  Q1              13.97 ± 0.06                  Q1              13.98 ± 0.07
  Q2              13.95 ± 0.07                  Q2              13.95 ± 0.06
  Q3              14.09 ± 0.07                  Q3              14.00 ± 0.06
  Q4              14.00 ± 0.07                  Q4              14.08 ± 0.07
  *p* for trend   0.331                         *p* for trend   0.195
  Potassium                                     Vitamin C       
  Q1              13.96 ± 0.07                  Q1              14.01 ± 0.07
  Q2              13.99 ± 0.06                  Q2              13.95 ± 0.06
  Q3              14.07 ± 0.06                  Q3              14.01 ± 0.07
  Q4              13.98 ± 0.07                  Q4              14.03 ± 0.07
  *p* for trend   0.621                         *p* for trend   0.646

Data are presented as mean ± SE.

nutrients-10-00387-t006_Table 6

###### 

Odds ratios of nutritional factors for glaucoma in subjects with intraocular pressure ≤21 mmHg.

  Nutrient      OR (95% CI)         *p* for Trend   Nutrient     OR (95% CI)         *p* for Trend
  ------------- ------------------- --------------- ------------ ------------------- ---------------
  Crude fiber                                       Vitamin A                        
  Q1            Reference                           Q1           Reference           
  Q2            0.99 (0.77--1.21)   0.311           Q2           1.01 (0.80--1.28)   0.161
  Q3            0.92 (0.71--1.21)                   Q3           0.94 (0.72--1.24)   
  Q4            0.87 (0.66--1.17)                   Q4           0.82 (0.62--1.09)   
  Ash                                               β-Carotene                       
  Q1            Reference                           Q1           Reference           
  Q2            0.82 (0.62--1.08)   0.438           Q2           0.98 (0.77--1.24)   0.251
  Q3            0.98 (0.73--1.30)                   Q3           0.89 (0.68--1.18)   
  Q4            0.80 (0.56--1.16)                   Q4           0.86 (0.66--1.13)   
  Calcium                                           Retinol                          
  Q1            Reference                           Q1           Reference           
  Q2            0.91 (0.69--1.19)   0.635           Q2           1.17 (0.92--1.48)   0.210
  Q3            0.74 (0.56--0.99)                   Q3           0.99 (0.76--1.28)   
  Q4            0.99 (0.73--1.35)                   Q4           0.86 (0.64--1.15)   
  Phosphorus                                        Thiamin                          
  Q1            Reference                           Q1           Reference           
  Q2            0.88 (0.67--1.15)   0.440           Q2           0.98 (0.75--1.30)   0.428
  Q3            0.85 (0.62--1.17)                   Q3           0.85 (0.62--1.17)   
  Q4            0.86 (0.55--1.34)                   Q4           0.90 (0.61--1.33)   
  Iron                                              Riboflavin                       
  Q1            Reference                           Q1           Reference           
  Q2            0.77 (0.59--0.99)   0.091           Q2           0.91 (0.70--1.18)   0.154
  Q3            0.82 (0.61--1.12)                   Q3           0.77 (0.57--1.04)   
  Q4            0.73 (0.53--1.01)                   Q4           0.82 (0.56--1.18)   
  Sodium                                            Niacin                           
  Q1            Reference                           Q1           Reference           
  Q2            1.01 (0.77--1.31)   0.364           Q2           0.82 (0.63--1.09)   0.022
  Q3            1.25 (0.96--1.62)                   Q3           0.71 (0.51--0.99)   
  Q4            1.06 (0.78--1.46)                   Q4           0.63 (0.41--0.96)   
  Potassium                                         Vitamin C                        
  Q1            Reference                           Q1           Reference           
  Q2            0.90 (0.69--1.19)   0.128           Q2           1.10 (0.85--1.41)   0.455
  Q3            0.86 (0.62--1.18)                   Q3           0.98 (0.74--1.29)   
  Q4            0.74 (0.50--1.08)                   Q4           0.91 (0.68--1.23)   

Data are presented OR (95% CI). Statistics were carried out using Logistic regression. Odds ratios are adjusted for age, gender, income, education, occupation, smoking, drink, physical activity, diabetes, hypertension, intraocular pressure, total energy.

nutrients-10-00387-t007_Table 7

###### 

Odds ratios of nutritional factors for glaucoma after exclusion of participants taking supplements.

  Nutrient      OR (95% CI)         *p* for Trend   Nutrient     OR (95% CI)         *p* for Trend
  ------------- ------------------- --------------- ------------ ------------------- ---------------
  Crude fiber                                       Vitamin A                        
  Q1            Reference                           Q1           Reference           
  Q2            0.96 (0.73--1.28)   0.410           Q2           0.92 (0.70--1.21)   0.481
  Q3            0.88 (0.64--1.20)                   Q3           0.95 (0.69--1.30)   
  Q4            0.90 (0.65--1.24)                   Q4           0.87 (0.63--1.21)   
  Ash                                               β-Carotene                       
  Q1            Reference                           Q1           Reference           
  Q2            0.84 (0.61--1.16)   0.377           Q2           0.94 (0.71--1.25)   0.505
  Q3            0.91 (0.65--1.27)                   Q3           0.89 (0.65--1.22)   
  Q4            0.80 (0.53--1.21)                   Q4           0.91 (0.67--1.24)   
  Calcium                                           Retinol                          
  Q1            Reference                           Q1           Reference           
  Q2            0.91 (0.65--1.26)   0.618           Q2           1.12 (0.85--1.48)   0.125
  Q3            0.78 (0.56--1.08)                   Q3           0.91 (0.68--1.21)   
  Q4            0.96 (0.67--1.37)                   Q4           0.82 (0.60--1.13)   
  Phosphorus                                        Thiamin                          
  Q1            Reference                           Q1           Reference           
  Q2            0.83 (0.60--1.15)   0.419           Q2           0.92 (0.67--1.25)   0.267
  Q3            0.82 (0.56--1.20)                   Q3           0.89 (0.62--1.29)   
  Q4            0.82 (0.47--1.40)                   Q4           0.76 (0.48--1.20)   
  Iron                                              Riboflavin                       
  Q1            Reference                           Q1           Reference           
  Q2            0.70 (0.52--0.94)   0.0502          Q2           0.81 (0.60--1.08)   0.009
  Q3            0.88 (0.63--1.23)                   Q3           0.63 (0.44--0.89)   
  Q4            0.64 (0.44--0.91)                   Q4           0.60 (0.39--0.93)   
  Sodium                                            Niacin                           
  Q1            Reference                           Q1           Reference           
  Q2            1.00 (0.74--1.35)   0.424           Q2           0.73 (0.52--1.02)   0.035
  Q3            1.26 (0.94--1.69)                   Q3           0.75 (0.51--1.12)   
  Q4            1.05 (0.73--1.50)                   Q4           0.54 (0.33--0.90)   
  Potassium                                         Vitamin C                        
  Q1            Reference                           Q1           Reference           
  Q2            0.70 (0.51--0.96)   0.100           Q2           1.14 (0.86--1.53)   0.726
  Q3            0.75 (0.53--1.07)                   Q3           1.01 (0.75--1.36)   
  Q4            0.68 (0.44--1.04)                   Q4           1.11 (0.79--1.55)   

Data are presented OR (95% CI). Statistics were carried out using Logistic regression, adjusted for age, gender, income, education, occupation, smoking, drink, Physical activity, diabetes, hypertension, Intraocular pressure, total energy.
